NDC 16729-394 - amlodipine besylate and olmesartan medoxomil
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-394
- Package NDCs from labels
- 16729-394-10, 16729-394-15, 16729-394-16, 16729-394-17
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2019-08-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| POVIDONE K30 - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2019-08-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-394-10 | amlodipine besylate and olmesartan medoxomil | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 2 | |
| 16729-394-15 | amlodipine besylate and olmesartan medoxomil | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 2 | |
| 16729-394-16 | amlodipine besylate and olmesartan medoxomil | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 2 | |
| 16729-394-17 | amlodipine besylate and olmesartan medoxomil | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine and Valsartan | AMLODIPINE AND VALSARTAN | Alembic Pharmaceuticals Limited | a9c442dc-749e-4de0-bca3-1044eb78da72 | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine besylate and Olmesartran medoxomil | AMLODIPINE BESYLATE AND OLMESARTRAN MEDOXOMIL | Alembic Pharmaceuticals Limited | cb2df7f7-fee8-42ba-8936-0788c4fcc0cb | 2023-01-23 | Boxed warning, Warnings, Adverse reactions | 730872 730866 730861 730869 864V2Q084H 6M97XTV3HD |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 8c65d555-8db8-40d9-be30-309ef09f19be | 2023-01-19 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Alembic Pharmaceuticals Limited | ac08ea7d-f529-42ca-850a-a0ecce7dc830 | 2023-01-18 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Josie Maran Argan Daily Moisturizer SPF47 | ZINC OXIDE, TITANIUM DIOXIDE | Autumn Harp, Inc. | 027821e6-db7d-4c03-956a-00313488ebc7 | 2023-01-14 | Boxed warning, Warnings | 15FIX9V2JP |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Dr.Reddy's Laboratories Limited | f12f18bb-7ddb-e7dc-4edd-32f4ac212bca | 2022-12-23 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Dr.Reddy's Laboratories Limited | ca014f06-982c-6fe1-9948-a3701dd35d34 | 2022-12-23 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Unichem Pharmaceuticals (USA), Inc. | a516b336-8f60-4b86-8921-c7d6c07629f2 | 2022-12-05 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | Proficient Rx LP | 29a0d87e-6afb-4766-9045-1963c5b0d183 | 2022-11-01 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| amlodipine besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | f3482709-c5c3-4bd0-8067-ad57f31bb525 | 2022-10-18 | Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE AND VALSARTAN | AMLODIPINE AND VALSARTAN | Lupin Pharmaceuticals,Inc. | e05dd72c-7475-422e-bf8e-73148929450e | 2022-06-01 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Proficient Rx LP | 445d1274-7249-476b-ad90-ff93aee56f6d | 2022-06-01 | Warnings, Adverse reactions | 864V2Q084H |
| Addiclenz | BETA VULGARIS, BOLDO, CHELIDONIUM MAJUS, PETROSELINUM SATIVUM, TARAXACUM OFFICINALE, ARSENICUM ALBUM, BISPHENOL A, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, ZINCUM METALLICUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYL PARABEN, PROPYL PARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | Deseret Biologicals, Inc. | e39235ea-2a2f-44a7-92d6-fb1d428ebabd | 2022-05-12 | Warnings | 15FIX9V2JP |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Proficient Rx LP | 5f3ac64c-6e33-40c1-9b8e-dc0c8dd7e8d6 | 2022-04-01 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine besylate | AMLODIPINE BESYLATE | Exelan Pharmaceuticals, Inc. | 1a24433f-4464-4c6d-9456-ed1ce38e8ec4 | 2022-03-12 | Warnings, Adverse reactions | 864V2Q084H |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Solco Healthcare US, LLC. | 6e602f81-1cc3-4ae1-8bdf-85572e35cf73 | 2022-03-04 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Warm Ivory | OCTINOXATE, TITANIUM DIOXIDE | BCM Cosmetique SAS | 97e7ece8-a705-4988-ba52-6d3f11573521 | 2021-12-01 | Warnings | 15FIX9V2JP |
| No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Chestnut | OCTINOXATE, TITANIUM DIOXIDE | BCM Cosmetique SAS | 6a44f926-11b4-4bc4-8d5d-721a89c4f0cc | 2021-11-09 | Warnings | 15FIX9V2JP |
| No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Hazelnut | OCTINOXATE, TITANIUM DIOXIDE | BCM Cosmetique SAS | b58af664-b0fd-4585-8417-7c20954d7aff | 2021-11-09 | Warnings | 15FIX9V2JP |
| No7 Restore and Renew Multi Action Serum Foundation Sunscreen Broad Spectrum SPF 20 Umber | OCTINOXATE, TITANIUM DIOXIDE | BCM Cosmetique SAS | 7bbd1334-fae8-4274-b927-a099af764345 | 2021-11-09 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.